PBE Holdings: Invesco Biotechnology & Genome Top Holdings
NYSEARCA: PBEInvescoHealthETFUSD
96.90+2.64 (+2.80%)
At close: Oct 9, 3:15 PM ET · Delayed 15 min
PBE portfolio concentration
The Invesco Biotechnology & Genome ETF (PBE) reports 10 holdings. Its biggest position is Natera Inc (NTRA) at 6.23% of assets. The top 10 holdings account for 48.2% of the portfolio, a moderately concentrated portfolio.
10 positions carry a weight of 1% or more. Based on the weights listed, PBE behaves like an equal-weighted fund of about 41 stocks (the inverse Herfindahl index), a measure of how diversified it really is. Holdings and weights change over time as the fund rebalances and as share prices move.
Click any ticker to see that company's stock price, financials and news.
Summary generated from market data by MetaCap's automated system. Methodology
PBE holdings by weight
| # | Holding | Weight |
|---|---|---|
| 1 | NTRANatera Inc | 6.23% |
| 2 | ILMNIllumina Inc | 6.17% |
| 3 | BIIBBiogen Inc | 5.19% |
| 4 | GILDGilead Sciences Inc | 5.08% |
| 5 | AMGNAmgen Inc | 4.84% |
| 6 | VRTXVertex Pharmaceuticals Inc | 4.80% |
| 7 | RPRXRoyalty Pharma PLC Class A | 4.77% |
| 8 | REGNRegeneron Pharmaceuticals Inc | 4.62% |
| 9 | MRNAModerna Inc | 3.36% |
| 10 | NVAXNovavax Inc | 3.17% |